hero pervas id 2
Open For Investment

PervasID

EIS Eligible Investment Opportunity

“The implementation of RFID’s (Radio Frequency Identification) could potentially save every NHS trust up to £5m across medical device asset management, patient pathway management, and medicine inventory management.”

PervasID designs, manufactures and supplies passive RFID reader systems to a range of customers across various industries - industrial, retail, healthcare, security and logistics.

Firstname Lastname & Firstname Lastname

Position & Position, Company

Overview

The world's most accurate passive Radio Frequency Identification (RFID) technology.

PervasID is a fast-growing technology company that designs and supplies world-leading, passive RFID fixed reader systems for automating inventory tracking, stock taking and asset management processes.

There are two types of RFID tags; active and passive. Active tags have internal batteries that power data transmission into readers. They have a long range but tend to be costly. Passive tags however rely on RFID readers to activate them as they don't have an internal power source. The readers typically need to be within 1-2 metres of the tag to power them and because of this blind spots can occur, decreasing the accuracy of the readers. The lack of accuracy with the existing passive readers in the market is a problem that needs addressing.

PervasID's unmatched patented solution solves the traditional problems concerning passive RFID solutions regarding accuracy, detection range and cost. This is achieved through an entirely new way of addressing the underlying physics of RFID, as well as advanced signal processing. 


The Team

Executive Team with a proven track record

Dr Sabesan Sithamparanathan OBE Founder & President
Peter Oram CEO
Adrian Watson CFO
Moray Wright Chairman
Barbara Albizuri NED
Michael Mahan NED

World-leading RFID readers offering unrivalled tag detection capabilities.  

Highlights

Key Investment Highlights

A snapshot of the Key Investment Highlights associated with PervasID and their EIS-eligible investment opportunity.

Numbers-01
EXPERIENCED
TEAM

An experienced leadership team with a proven track record. Founded by Dr Sabesan Sithamparanathan OBE, multi-award winning entrepreneur with over 15 years’ experience and led by Peter Oram, an accomplished growth-focused executive offering 25+ years of robust experience leading B2B operations.

Numbers-02
HIGHLY DEFINED
TARGET MARKET

PervasID has received strong customer engagement in the industrial, retail and healthcare sectors. Initially focusing on these three target verticals but with strong potential to expand once the sales and commercial departments have been developed further.

Numbers-03
CLEAR VALUE
PROPOSITION

PervasID has built passive RFID readers with a near-100% accuracy, low installation costs and higher speed allowing for continuous, real time data. At present, handheld passive RFID readers lead the market, but with accuracy rates of circa 80%, alternative solutions were needed.

Numbers-04
PROVEN REVENUE
MODEL

For retail clients, revenues range from £8k for a small store and £30k for a larger store. With strong market growth and increased adoption of passive RFID solutions PervasID is landing new customers and expecting strong revenue growth.

Numbers-05
STRONG
PARTNERSHIPS

PervasID have agreements in place with SML, Nedap and GreyOrange to provide greater access to the retail market, aiming to accelerate the sales process.

Numbers-06
COMMERCIAL
TRACTION

PervasID have onboarded customers spanning healthcare, logistics, retail, and industry. Clients include Stanley Black & Decker, Guy’s and St Thomas’ NHS, Lyngsoe, and Securitas.

Numbers-07
DEFENSIBLE
IP

The business has eight patents either granted, filed or in-progress. PervasID has successfully moved from one patent protecting a single product to eight patents covering the complete product lines.

Numbers-08
CO-
INVESTMENT

£10m has been raised to date, with existing investors including Parkwalk Advisors, a leading investor in world-changing tech emerging out of UK universities. The current round is raising £4m, with £3.75m already committed from Parkwalk Advisors, Maven Capital Partners and Maven Cognition.


Open For Investment

PervasID

EIS Eligible Investment Opportunity
Download the Opportunity Note to discover the full details of the current investment opportunity into PervasID.

PervasID


2011


  • Fundamental research undertaken at the University of Cambridge as part of the Intelligent Airport Project. 
  • PervasID spin-out commercially from the University of Cambridge.
  • Raised £10m to date with key investors including Parkwalk Advisors.

  • Won major roll-out customers including Stanley Black & Decker.

  • Signed a strategic partnership with SML to bring high-accuracy, hands-free UHF RFID product visibility in the retail market.

  • Peter Oram joined as CEO, with relevant experience of scaling an RFID solutions provider in the automotive sector.

  • Signed additional agreements with Nedap, and GreyOrange, aiming to accelerate the sales process by collaborating with three of the largest retail software providers.

3WSIBW8AU9ECVFPPZT0M

Now


FAQs

Want to find out more about investing with GCV?

Should you have any further questions regarding this investment opportunity, please reach to the Investment Team, you can contact us at any point 

  • Contact Millie Haigh - Investor Relations Director - millie.gerber@growthcapitalventures.co.uk

  • There are no joinings fees. Membership of GCV Invest is completely free, giving you access to well researched, carefully selected investment opportunities across asset classes, all with the potential to provide portfolio diversification and superior investment returns.

    Transaction fees are only charged at the point of a liquidity event occurring (such as a trade sale or IPO for private companies and completion of a residential development for property transactions). At this point, 7.5% of the investment gain is charged before funds are provided back to you as an investor.

    Whilst dividend payments should not be expected from early-stage companies, more mature companies may include dividend payments, if and when they are paid, 7.5% of the dividend amount is charged to investors.

  • Where a wide range of information on tax efficient investing is readily available at the touch of a button, ensuring sources are up to date, unbiased and accurate can be a crucial task when researching the ever-evolving tax efficient investing landscape  - why not try the GCV Invest content library as a starting point?

  • GCV offer experienced investors the opportunity to invest in carefully researched early-stage businesses with high growth potential.

     

    We specialise in opportunities that are SEIS and EIS qualifying, offering investors generous income tax reliefs of between 30% and 50% when making the investment and no capital gains tax on investment profits at realisation stage.

Don't invest unless you're prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong.
Risk Summary

Estimated reading time: 2 min

Due to the potential for losses, the Financial Conduct Authority (FCA) considers this investment to be high risk.

What are the key risks?

  • You could lose all the money you invest
  • Most investments are shares in start-up businesses or bonds issued by them. Investors in these shares or bonds often lose 100% of the money they invested, as most start-up businesses fail.
  • Checks on the businesses you are investing in, such as how well they are expected to perform, may not have been carried out by the platform you are investing through. You should do your own research before investing.

You won't get your money back quickly

  • Even if the business you invest in is successful, it will likely take several years to get your money back.
  • The most likely way to get your money back is if the business is bought by another business or lists its shares on an exchange such as the London Stock Exchange. These events are not common.
  • Start-up businesses very rarely pay you back through dividends. You should not expect to get your money back this way.
  • Some platforms may give you the opportunity to sell your investment early through a 'secondary market' or 'bulletin board', but there is no guarantee you will find a buyer at the price you are willing to sell.

Don't put all your eggs in one basket

  • Putting all your money into a single business or type of investment for example, is risky. Spreading your money across different investments makes you less dependent on any one to do well. A good rule of thumb is not to invest more than 10% of your money in high-risk investments. Learn more here.

The value of your investment can be reduced

  • If your investment is shares, the percentage of the business that you own will decrease if the business issues more shares. This could mean that the value of your investment reduces, depending on how much the business grows. Most start-up businesses issue multiple rounds of shares.
  • These new shares could have additional rights that your shares don't have, such as the right to receive a fixed dividend, which could further reduce your chances of getting a return on your investment.

You are unlikely to be protected if something goes wrong

  • Protection from the Financial Services Compensation Scheme (FSCS), in relation to claims against failed regulated firms, does not cover poor investment performance. Try the FSCS investment protection checker.
  • Protection from the Financial Ombudsman Service (FOS) does not cover poor investment performance. If you have a complaint against an FCA-regulated platform, FOS may be able to consider it. Learn more about FOS protection here.

If you are interested in learning more about how to protect yourself, visit the FCA's website here.

For further information about investment-based crowdfunding, visit the crowdfunding section of the FCA's website here.

Driving Growth.
Creating Value.
Delivering Impact.

Backed by

Growth Capital Ventures (GCV) is backed by funds managed by Maven Capital Partners, one of the UK’s leading private equity and alternative asset managers.